CRISM Therapeutics Corporation (AIM:CRTX)

CRISM Therapeutics Revenue

CRISM Therapeutics had revenue of 231.00K GBP in the half year ending December 31, 2025. This brings the company's revenue in the last twelve months to 352.00K, up 1,308.00% year-over-year. In the year 2025, CRISM Therapeutics had annual revenue of 231.00K with 824.00% growth.

• Revenue (ttm): 352.00K
• Revenue Growth: +1,308.00%
• P/S Ratio: 21.93
• Revenue / Employee: 88.00K
• Employees: 4
• Market Cap: 7.72M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	231.00K	206.00K	824.00%
Dec 31, 2024	25.00K	-20.00K	-44.44%
Dec 31, 2023	45.00K	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Jun 26, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 22, 2026

Data Sources Report a data error